NEW YORK (GenomeWeb) – Invitae has filed a shelf registration with the US Securities and Exchange Commission, under which it may offer up to $250 million of common and/or preferred stock, debt securities, depositary shares, or warrants.

The company also said that it signed a sales agreement with Cowen and Company allowing for the sale up to $75 million of its common stock.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.